R 021954Z JUL 20 MID110000802701U
FM SECNAV WASHINGTON DC
INFO SECNAV WASHINGTON DC
CNO WASHINGTON DC
CMC WASHINGTON DC
MSGID/GENADMIN/SECNAV WASHINGTON DC/-/JUN//
SUBJ/PROHIBITION ON THE USE OF HEMP PRODUCTS UPDATED//
NARR/REF A IS OFFICE OF UNDER SECRETARY OF DEFENSE FOR PERSONNEL AND
READINESS MEMORANDUM / ADOPTION OF PUNITIVE GENERAL ORDERS TO ADDRESS USE OF
HEMP PRODUCTS 26FEB20.
REF B IS SECNAVINST 5300.28F MILITARY SUBSTANCE ABUSE PREVENTION AND
RMKS/1. On December 20, 2018, the President signed into law the Agriculture
Improvement Act of 2018, removing industrial hemp from the Controlled
Substances Act (21 U.S.C. 802(16)) and excluding from the definition of
marijuana those hemp products containing up to 0.3 percent
tetrahydrocannabinol (THC) on a dry weight basis. THC in marijuana and in
those hemp products containing more than 0.3 percent THC remain illegal.
2. Due to this change in the law, new hemp products are commercially
available in the United States, the normal use of which could cause a
positive urinalysis result. The United States Food and Drug Administration
(FDA) does not determine or certify the THC concentration of commercially
available hemp products, such as cannabidiol (also known as CBD).
Accordingly, these products may contain appreciable levels of THC, yet omit
any reference to THC on the product label and/or list an inaccurate THC
concentration. Consequently, Sailors and Marines cannot rely on the
packaging and labeling of hemp products in determining whether the product
contains THC concentrations that could cause a positive urinalysis result
3. Substance misuse by members of the Armed Forces is incompatible with
military standards of good order and discipline, performance, and operational
readiness. It is the goal of the Department of the Navy to eliminate
substance abuse. The use of products containing or derived from hemp may
interfere with the Navy and Marine Corps Drug Testing Program and result in
the reporting of unlawful levels of THC in Sailors and Marines. In order to
ensure military readiness and the reliability and integrity of the Drug
Testing Program, the knowing ingestion (orally, intravenously, through
smoking/vaporization, or through other means) of products containing, or
products derived from, hemp is prohibited reference (a) and (b). Failure by
military personnel to comply with this ALNAV is a violation of the Uniform
Code of Military Justice (UCMJ), Article 92, Failure to Obey a Lawful General
Order, and any other UCMJ article that may apply. Violations may result in
administrative and/or disciplinary action.
4. Effective immediately:
a. Sailors and Marines are prohibited from knowingly using any product
made or derived from hemp (as defined in 7 U.S.C. 1639o), including CBD,
regardless of the products THC concentration, claimed or actual, and
regardless of whether such product may lawfully be bought, sold, and used
under the law applicable to civilians. Use means to inject, ingest, inhale,
or otherwise introduce into the human body.
b. This prohibition does not apply to the ingestion, consumption, or
application of cannabinoid formulations approved as drugs by the FDA
Administration for which the Service member has a valid prescription, such as
Dronabinol (Marinol, Syndros) and cannabidiol (Epidiolex). A prescription
will be deemed valid if issued by the Service Members assigned Department of
Defense approved medical service provider or a civilian medical professional
whose care the Service member was referred or directed to seek reference (b).
5. ALNAV 057-19 is superseded by this update.
6. The primary point of contact for this message is Assistant Secretary of
the Navy, (Manpower and Reserve Affairs), Drug Demand Reduction Program.
a. For United States Marine Corps Commands: Mr. Eric Hollins,
email@example.com or by phone at (703) 784-9526.
b. For Navy Commands: Ms. LaNorfeia Parker, firstname.lastname@example.org,
or by phone at (901) 874-4900.
7. This ALNAV is effective immediately until superseded or cancelled,
whichever comes first.
8. Released by the Honorable Kenneth J. Braithwaite, Secretary of the